Search results
Results from the WOW.Com Content Network
Diltiazem, sold under the brand name Cardizem among others, is a nondihydropyridine calcium channel blocker medication used to treat high blood pressure, angina, and certain heart arrhythmias. [9] It may also be used in hyperthyroidism if beta blockers cannot be used. [ 9 ]
Benzodiazepines require special precautions if used in the elderly, during pregnancy, in children, in alcoholics, or in other drug-dependent individuals and individuals with comorbid psychiatric disorders. [18] Triazolam belongs to the Pregnancy Category X of the FDA. [19] [1] It is known to have the potential to cause birth defects.
Suvorexant is used for the treatment of insomnia, characterized by difficulties with sleep onset and/or sleep maintenance, in adults. [2] [6] At a dose of 15 to 20 mg and in terms of treatment–placebo difference, it reduces time to sleep onset by up to 10 minutes, reduces time awake after sleep onset by about 15 to 30 minutes, and increases total sleep time by about 10 to 20 minutes. [2]
Potential complications of insomnia [19] Symptoms of insomnia: [20] Difficulty falling asleep, including difficulty finding a comfortable sleeping position; Waking during the night, being unable to return to sleep [21] and waking up early; Not able to focus on daily tasks, difficulty in remembering; Daytime sleepiness, irritability, depression ...
The presence or lack of insomnia symptoms did not modify the effects of sleep duration in this study. [ 83 ] The United Kingdom Biobank studied nearly 500,000 adults who had no cardiovascular disease, and the subjects who slept less than six hours a day were associated with a 20 percent increase in the risk of developing myocardial infarction ...
Insomnia disorder (primary insomnia), chronic difficulty in falling asleep or maintaining sleep when no other cause is found for these symptoms. Insomnia can also be comorbid with or secondary to other disorders. Kleine–Levin syndrome, a rare disorder characterized by persistent episodic hypersomnia and cognitive or mood changes. [84]
In medicine, insomnia is measured using the Athens insomnia scale. It was introduced in the year 2000 by a group of researchers [ 1 ] from Athens, Greece to assess the insomnia symptoms in patients with sleep disorders.
Insomnia: Insomnia is defined as the subjective perception of difficulty with sleep initiation, duration, consolidation, or quality that occurs despite adequate opportunity for sleep, and that results in some form of daytime impairment. [4] Adjustment sleep disorder (acute insomnia) 307.41 F 51.02 Psychophysiological insomnia 307.42 F 51.04